Zack Armen | Head-Investor Relations |
Jennifer Buell | President and Chief Executive Officer |
Marc Van Dijk | Chief Scientific Officer |
Christine Klaskin | Principal Financial and Accounting Officer |
Emily Bodnar | H.C. Wainwright |
Jack Allen | Baird |
Matthew Phipps | William Blair |
Ladies and gentlemen, thank you for standing by. Welcome to the MiNK Therapeutics’ First Quarter 2023 Financial Results Call. I would now like to turn the call over to Zack Armen, Head of Investor Relations. Please go ahead.
Thank you, operator, and thank you all for joining us today.